CD40-binding APC-activating molecules
AssigneePangenetics BV
InventorsDavid Thomas, Mark De Boer, Pieter C.J.M. Res, Peter J. Simons
Life of this patent
Estimating the term…
Abstract
Disclosed are agonist anti-CD40 molecules, including monoclonal antibodies, which can bind to and stimulate professional and non-professional human antigen-presenting cells (“APCs”), enhance the stimulatory effect of CD40L on CD40 positive cells and/or induce phenotypical maturation of monocyte derived dendritic cells. Several such monoclonal antibodies are provided, and cell lines producing them have been deposited at the American Type Culture Collection.
Claims20
Agonist anti-CD40 molecules that can bind to and stimulate professional or non-professional human APCs.
Agonist anti-CD40 molecules which enhance the stimulatory effect of CD40L on CD40 positive cells.
Agonistic anti-CD40 molecules which induce phenotypical and functional maturation of monocyte derived dendritic cells.
A bispecific agonist anti-CD40 monoclonal antibody wherein each specificity is for a different epitope on CD40.
Dependencies are inferred from the claim text.